More importantly, our previous study found that SGLT1 inhibition could attenuate apoptosis and relieve myocardial fibrosis, thus suppressing DCM development by regulating the JNK/p38 signaling pathway (Lin et al., 2021). The gene discussed is SLC5A1; the disease is familial dilated cardiomyopathy.